Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AABA
1
DELISTED
Altaba Inc
AABA
| $674M | 1.05% |
11,631,633
-244,076
| -2% | -$15.1M |
|
2
Apple
AAPL
$4.51T
| $517M | 0.81% |
13,121,428
-1,162,460
| -8% | -$56.4M |
|
3
Oracle
ORCL
$422B
| $454M | 0.71% |
10,051,913
+5,160,700
| +106% | +$247M |
|
4
Qualcomm
QCOM
$169B
| $402M | 0.63% |
7,057,645
+2,121,240
| +43% | +$129M |
|
|
5
Starbucks
SBUX
$122B
| $390M | 0.61% |
6,056,412
+5,926,793
| +4,572% | +$371M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $381M | 0.59% |
5,942,269
+5,129,102
| +631% | +$379M |
|
7
Merck
MRK
$376B
| $375M | 0.58% |
5,141,579
+1,157,900
| +29% | +$81.7M |
|
|
8
Bristol-Myers Squibb
BMY
$137B
| $374M | 0.58% |
7,202,976
+4,890,444
| +211% | +$263M |
|
|
SHPG
9
DELISTED
Shire pic
SHPG
| $362M | 0.56% |
2,080,489
+1,168,662
| +128% | +$204M |
|
10
Visa
V
$693B
| $343M | 0.54% |
2,600,597
+27,392
| +1% | +$3.78M |
|
11
Citigroup
C
$221B
| $311M | 0.48% |
5,972,816
+993,364
| +20% | +$62.9M |
|
12
Alphabet (Google) Class C
GOOG
$4.18T
| $308M | 0.48% |
5,951,080
+3,888,540
| +189% | +$208M |
|
13
Honeywell
HON
$68.4B
| $291M | 0.45% |
2,334,418
+1,359,081
| +139% | +$186M |
|
|
RHT
14
DELISTED
Red Hat Inc
RHT
| $278M | 0.43% |
1,580,220
+1,178,217
| +293% | +$187M |
|
15
Intercontinental Exchange
ICE
$90.5B
| $277M | 0.43% |
3,674,867
+2,224,434
| +153% | +$170M |
|
16
Intel
INTC
$476B
| $275M | 0.43% |
5,864,637
+5,251,782
| +857% | +$246M |
|
17
Gilead Sciences
GILD
$181B
| $270M | 0.42% |
4,315,166
+2,576,875
| +148% | +$180M |
|
18
Mastercard
MA
$509B
| $264M | 0.41% |
1,400,813
+1,219,620
| +673% | +$242M |
|
|
19
Tesla
TSLA
$1.43T
| $261M | 0.41% |
11,773,770
+11,748,135
| +45,828% | +$253M |
|
20
Lowe's Companies
LOW
$121B
| $260M | 0.4% |
2,809,693
+1,075,524
| +62% | +$104M |
|
|
TFCFA
21
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $257M | 0.4% |
5,334,168
+1,130,325
| +27% | +$53.6M |
|
22
CSX Corp
CSX
$95.6B
| $255M | 0.4% |
12,291,867
-6,101,790
| -33% | -$140M |
|
23
CVS Health
CVS
$119B
| $253M | 0.39% |
3,859,106
+3,303,892
| +595% | +$247M |
|
24
Wells Fargo
WFC
$254B
| $249M | 0.39% |
5,393,500
+915,517
| +20% | +$46.9M |
|
25
Booking.com
BKNG
$158B
| $248M | 0.39% |
3,606,075
+3,435,300
| +2,012% | +$252M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.